Sector Chart Interpace Biosciences, Inc.

Stocks

IDXG

US46062X4025

Healthcare Facilities & Services

Delayed OTC Markets 02:15:07 2026-09-30 pm EDT			5-day change	1st Jan Change
6.390 ^USD	-0.47%		-1.24%	+3.89%

Aug. 10	Interpace Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
May. 12	Interpace Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Medical & Diagnostic Laboratories

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
INTERPACE BIOSCIENCES, INC.	35.41M	-	-	-	-	-
CVS HEALTH CORPORATION	109B
HCA HEALTHCARE, INC.	91.66B
NATERA, INC.	58.88B					-
FRESENIUS SE & CO. KGAA	27.78B
QUEST DIAGNOSTICS INCORPORATED	25.51B